<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2018-01-31" version="189">
<accession>Q13627</accession>
<accession>O60769</accession>
<accession>Q92582</accession>
<accession>Q92810</accession>
<accession>Q9UNM5</accession>
<name>DYR1A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Dual specificity tyrosine-phosphorylation-regulated kinase 1A</fullName>
<ecNumber evidence="19 23 26 28">2.7.12.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Dual specificity YAK1-related kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>HP86</fullName>
</alternativeName>
<alternativeName>
<fullName>Protein kinase minibrain homolog</fullName>
<shortName>MNBH</shortName>
<shortName>hMNB</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">DYRK1A</name>
<name type="synonym">DYRK</name>
<name type="synonym">MNB</name>
<name type="synonym">MNBH</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Genomics" volume="38" first="331" last="339">
<title>Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome 'critical region'.</title>
<authorList>
<person name="Song W.J."/>
<person name="Sternberg L.R."/>
<person name="Kasten-Sportes C."/>
<person name="van Keuren M.L."/>
<person name="Chung S.H."/>
<person name="Slack A.C."/>
<person name="Miller D.E."/>
<person name="Glover T.W."/>
<person name="Chiang P.W."/>
<person name="Lou L."/>
<person name="Kurnit D.W."/>
</authorList>
<dbReference type="PubMed" id="8975710"/>
<dbReference type="DOI" id="10.1006/geno.1996.0636"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG)</scope>
<scope>VARIANT PRO-679</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Hum. Mol. Genet." volume="5" first="1305" last="1310">
<title>A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region.</title>
<authorList>
<person name="Guimera J."/>
<person name="Casas C."/>
<person name="Pucharcos C."/>
<person name="Solans A."/>
<person name="Domenech A."/>
<person name="Planas A.M."/>
<person name="Ashley J."/>
<person name="Lovett M."/>
<person name="Estivill X."/>
<person name="Pritchard M.A."/>
</authorList>
<dbReference type="PubMed" id="8872470"/>
<dbReference type="DOI" id="10.1093/hmg/5.9.1305"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>POSSIBLE INVOLVEMENT IN DOWN SYNDROME</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Biochem. Biophys. Res. Commun." volume="225" first="92" last="99">
<title>Cloning of a human homolog of the Drosophila minibrain/rat Dyrk gene from 'the Down syndrome critical region' of chromosome 21.</title>
<authorList>
<person name="Shindoh N."/>
<person name="Kudoh J."/>
<person name="Maeda H."/>
<person name="Yamaki A."/>
<person name="Minoshima S."/>
<person name="Shimizu Y."/>
<person name="Shimizu N."/>
</authorList>
<dbReference type="PubMed" id="8769099"/>
<dbReference type="DOI" id="10.1006/bbrc.1996.1135"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Genome Res." volume="7" first="47" last="58">
<title>Gene identification in 1.6-Mb region of the Down syndrome region on chromosome 21.</title>
<authorList>
<person name="Ohira M."/>
<person name="Seki N."/>
<person name="Nagase T."/>
<person name="Suzuki E."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
<person name="Hattori M."/>
<person name="Sakaki Y."/>
<person name="Eki T."/>
<person name="Murakami Y."/>
<person name="Saito T."/>
<person name="Ichikawa H."/>
<person name="Ohki M."/>
</authorList>
<dbReference type="PubMed" id="9037601"/>
<dbReference type="DOI" id="10.1101/gr.7.1.47"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Promyelocytic leukemia</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="Genomics" volume="57" first="407" last="418">
<title>Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome.</title>
<authorList>
<person name="Guimera J."/>
<person name="Casas C."/>
<person name="Estivill X."/>
<person name="Pritchard M.A."/>
</authorList>
<dbReference type="PubMed" id="10329007"/>
<dbReference type="DOI" id="10.1006/geno.1999.5775"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>POSSIBLE INVOLVEMENT IN DOWN SYNDROME</scope>
<scope>VARIANTS PHE-415 AND HIS-681</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1998" name="Genomics" volume="48" first="12" last="23">
<title>Transcriptional map of the 2.5-Mb CBR-ERG region of chromosome 21 involved in Down syndrome.</title>
<authorList>
<person name="Dahmane N."/>
<person name="Ait-Ghezala G."/>
<person name="Gosset P."/>
<person name="Chamoun Z."/>
<person name="Dufresne-Zacharia M.-C."/>
<person name="Lopes C."/>
<person name="Rabatel N."/>
<person name="Gassanova-Maugenre S."/>
<person name="Chettouh Z."/>
<person name="Abramowski V."/>
<person name="Fayet E."/>
<person name="Yaspo M.-L."/>
<person name="Korn B."/>
<person name="Blouin J.-L."/>
<person name="Lehrach H."/>
<person name="Poustka A."/>
<person name="Antonarakis S.E."/>
<person name="Sinet P.-M."/>
<person name="Creau N."/>
<person name="Delabar J.-M."/>
</authorList>
<dbReference type="PubMed" id="9503011"/>
<dbReference type="DOI" id="10.1006/geno.1997.5146"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 234-380</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="49573" last="49581">
<title>Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M.</title>
<authorList>
<person name="Zou Y."/>
<person name="Lim S."/>
<person name="Lee K."/>
<person name="Deng X."/>
<person name="Friedman E."/>
</authorList>
<dbReference type="PubMed" id="14500717"/>
<dbReference type="DOI" id="10.1074/jbc.M307556200"/>
</citation>
<scope>INTERACTION WITH RANBP9</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="2490" last="2498">
<title>Phosphorylation of Ser640 in muscle glycogen synthase by DYRK family protein kinases.</title>
<authorList>
<person name="Skurat A.V."/>
<person name="Dietrich A.D."/>
</authorList>
<dbReference type="PubMed" id="14593110"/>
<dbReference type="DOI" id="10.1074/jbc.M301769200"/>
</citation>
<scope>INTERACTION WITH WDR68</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-748 AND SER-758</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="PLoS Genet." volume="5" first="E1000397" last="E1000397">
<title>Genome-wide analysis of histidine repeats reveals their role in the localization of human proteins to the nuclear speckles compartment.</title>
<authorList>
<person name="Salichs E."/>
<person name="Ledda A."/>
<person name="Mularoni L."/>
<person name="Alba M.M."/>
<person name="de la Luna S."/>
</authorList>
<dbReference type="PubMed" id="19266028"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1000397"/>
</citation>
<scope>POLY-HISTIDINE REPEATS</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-145</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="13223" last="13232">
<title>DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1.</title>
<authorList>
<person name="Guo X."/>
<person name="Williams J.G."/>
<person name="Schug T.T."/>
<person name="Li X."/>
</authorList>
<dbReference type="PubMed" id="20167603"/>
<dbReference type="DOI" id="10.1074/jbc.M110.102574"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2011" name="Clin. Genet." volume="79" first="296" last="299">
<title>Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly.</title>
<authorList>
<person name="van Bon B.W."/>
<person name="Hoischen A."/>
<person name="Hehir-Kwa J."/>
<person name="de Brouwer A.P."/>
<person name="Ruivenkamp C."/>
<person name="Gijsbers A.C."/>
<person name="Marcelis C.L."/>
<person name="de Leeuw N."/>
<person name="Veltman J.A."/>
<person name="Brunner H.G."/>
<person name="de Vries B.B."/>
</authorList>
<dbReference type="PubMed" id="21294719"/>
<dbReference type="DOI" id="10.1111/j.1399-0004.2010.01544.x"/>
</citation>
<scope>INVOLVEMENT IN MRD7</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="5494" last="5505">
<title>Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activity.</title>
<authorList>
<person name="Papadopoulos C."/>
<person name="Arato K."/>
<person name="Lilienthal E."/>
<person name="Zerweck J."/>
<person name="Schutkowski M."/>
<person name="Chatain N."/>
<person name="Muller-Newen G."/>
<person name="Becker W."/>
<person name="de la Luna S."/>
</authorList>
<dbReference type="PubMed" id="21127067"/>
<dbReference type="DOI" id="10.1074/jbc.M110.157909"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="30497" last="30506">
<title>Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion.</title>
<authorList>
<person name="Yin X."/>
<person name="Jin N."/>
<person name="Gu J."/>
<person name="Shi J."/>
<person name="Zhou J."/>
<person name="Gong C.X."/>
<person name="Iqbal K."/>
<person name="Grundke-Iqbal I."/>
<person name="Liu F."/>
</authorList>
<dbReference type="PubMed" id="22767602"/>
<dbReference type="DOI" id="10.1074/jbc.M112.355412"/>
</citation>
<scope>INTERACTION WITH SRSF6</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2012" name="Science" volume="338" first="1619" last="1622">
<title>Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.</title>
<authorList>
<person name="O'Roak B.J."/>
<person name="Vives L."/>
<person name="Fu W."/>
<person name="Egertson J.D."/>
<person name="Stanaway I.B."/>
<person name="Phelps I.G."/>
<person name="Carvill G."/>
<person name="Kumar A."/>
<person name="Lee C."/>
<person name="Ankenman K."/>
<person name="Munson J."/>
<person name="Hiatt J.B."/>
<person name="Turner E.H."/>
<person name="Levy R."/>
<person name="O'Day D.R."/>
<person name="Krumm N."/>
<person name="Coe B.P."/>
<person name="Martin B.K."/>
<person name="Borenstein E."/>
<person name="Nickerson D.A."/>
<person name="Mefford H.C."/>
<person name="Doherty D."/>
<person name="Akey J.M."/>
<person name="Bernier R."/>
<person name="Eichler E.E."/>
<person name="Shendure J."/>
</authorList>
<dbReference type="PubMed" id="23160955"/>
<dbReference type="DOI" id="10.1126/science.1227764"/>
</citation>
<scope>INVOLVEMENT IN MRD7</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="Cell" volume="152" first="791" last="805">
<title>Dual specificity kinase DYRK3 couples stress granule condensation/dissolution to mTORC1 signaling.</title>
<authorList>
<person name="Wippich F."/>
<person name="Bodenmiller B."/>
<person name="Trajkovska M.G."/>
<person name="Wanka S."/>
<person name="Aebersold R."/>
<person name="Pelkmans L."/>
</authorList>
<dbReference type="PubMed" id="23415227"/>
<dbReference type="DOI" id="10.1016/j.cell.2013.01.033"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND TYR-145</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="J. Virol." volume="87" first="10348" last="10355">
<title>Dissection of the C-terminal region of E1A redefines the roles of CtBP and other cellular targets in oncogenic transformation.</title>
<authorList>
<person name="Cohen M.J."/>
<person name="Yousef A.F."/>
<person name="Massimi P."/>
<person name="Fonseca G.J."/>
<person name="Todorovic B."/>
<person name="Pelka P."/>
<person name="Turnell A.S."/>
<person name="Banks L."/>
<person name="Mymryk J.S."/>
</authorList>
<dbReference type="PubMed" id="23864635"/>
<dbReference type="DOI" id="10.1128/JVI.00786-13"/>
</citation>
<scope>INTERACTION WITH HADV5 E1A (MICROBIAL INFECTION)</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-529</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Nat. Commun." volume="1" first="86" last="86">
<title>Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A.</title>
<authorList>
<person name="Ogawa Y."/>
<person name="Nonaka Y."/>
<person name="Goto T."/>
<person name="Ohnishi E."/>
<person name="Hiramatsu T."/>
<person name="Kii I."/>
<person name="Yoshida M."/>
<person name="Ikura T."/>
<person name="Onogi H."/>
<person name="Shibuya H."/>
<person name="Hosoya T."/>
<person name="Ito N."/>
<person name="Hagiwara M."/>
</authorList>
<dbReference type="PubMed" id="20981014"/>
<dbReference type="DOI" id="10.1038/ncomms1090"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 126-490 IN COMPLEXES WITH THE SYNTHETIC INHIBITORS HARMINE AND INDY</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2012" name="J. Med. Chem." volume="55" first="9312" last="9330">
<title>Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B.</title>
<authorList>
<person name="Tahtouh T."/>
<person name="Elkins J.M."/>
<person name="Filippakopoulos P."/>
<person name="Soundararajan M."/>
<person name="Burgy G."/>
<person name="Durieu E."/>
<person name="Cochet C."/>
<person name="Schmid R.S."/>
<person name="Lo D.C."/>
<person name="Delhommel F."/>
<person name="Oberholzer A.E."/>
<person name="Pearl L.H."/>
<person name="Carreaux F."/>
<person name="Bazureau J.P."/>
<person name="Knapp S."/>
<person name="Meijer L."/>
</authorList>
<dbReference type="PubMed" id="22998443"/>
<dbReference type="DOI" id="10.1021/jm301034u"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.15 ANGSTROMS) OF 128-485</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="Bioorg. Med. Chem. Lett." volume="23" first="6610" last="6615">
<title>Pyrido[2,3-d]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors.</title>
<authorList>
<person name="Anderson K."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Dominique R."/>
<person name="Glenn K."/>
<person name="He Y."/>
<person name="Janson C."/>
<person name="Luk K.C."/>
<person name="Lukacs C."/>
<person name="Polonskaia A."/>
<person name="Qiao Q."/>
<person name="Railkar A."/>
<person name="Rossman P."/>
<person name="Sun H."/>
<person name="Xiang Q."/>
<person name="Vilenchik M."/>
<person name="Wovkulich P."/>
<person name="Zhang X."/>
</authorList>
<dbReference type="PubMed" id="24239188"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2013.10.055"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 127-485 IN COMPLEX WITH SYNTHETIC INHIBITOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="Structure" volume="21" first="986" last="996">
<title>Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition.</title>
<authorList>
<person name="Soundararajan M."/>
<person name="Roos A.K."/>
<person name="Savitsky P."/>
<person name="Filippakopoulos P."/>
<person name="Kettenbach A.N."/>
<person name="Olsen J.V."/>
<person name="Gerber S.A."/>
<person name="Eswaran J."/>
<person name="Knapp S."/>
<person name="Elkins J.M."/>
</authorList>
<dbReference type="PubMed" id="23665168"/>
<dbReference type="DOI" id="10.1016/j.str.2013.03.012"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 127-485 IN COMPLEXES WITH PEPTIDE SUBSTRATE AND INHIBITOR DJM2005</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF LYS-188 AND TYR-321</scope>
<scope>PHOSPHORYLATION AT TYR-111; TYR-140; TYR-159; TYR-177; SER-310; TYR-319; TYR-321; THR-402 AND TYR-449</scope>
<scope>ACTIVE SITE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] PRO-679</scope>
</reference>
<comment type="function">
<text evidence="8 10 19 20 26 29">Dual-specificity kinase which possesses both serine/threonine and tyrosine kinase activities. May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Modulates alternative splicing by phosphorylating the splice factor SRSF6 (By similarity). Exhibits a substrate preference for proline at position P+1 and arginine at position P-3. Has pro-survival function and negatively regulates the apoptotic process. Promotes cell survival upon genotoxic stress through phosphorylation of SIRT1. This in turn inhibits TP53 activity and apoptosis (By similarity).</text>
</comment>
<comment type="catalytic activity">
<text evidence="19 23 26 28">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="14 23">Inhibited by RANBP9 (PubMed:14500717). Inhibited by harmine, leucettamine B and leucettine L41 (PubMed:22998443).</text>
</comment>
<comment type="subunit">
<text evidence="8 14 15 22 28">Interacts RAD54L2/ARIP4 (By similarity). Interacts with CRY2 (By similarity). Interacts with RANBP9 (PubMed:14500717). Interacts with WDR68 (PubMed:14593110). Interacts with SRSF6 (PubMed:22767602). Interacts with SIRT1 (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="27">(Microbial infection) Interacts with human adenovirus 5 E1A protein (PubMed:23864635).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053596"/>
<interactant intactId="EBI-359808">
<id>P61962</id>
<label>DCAF7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053596"/>
<interactant intactId="EBI-741037">
<id>Q9BRK4</id>
<label>LZTS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053596"/>
<interactant intactId="EBI-491274">
<id>P06400</id>
<label>RB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053596"/>
<interactant intactId="EBI-971402">
<id>P28749</id>
<label>RBL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053596"/>
<interactant intactId="EBI-2349743">
<id>Q12815</id>
<label>TROAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1053621"/>
<interactant intactId="EBI-359815">
<id>P31946</id>
<label>YWHAB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="18 25">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="8">Nucleus speckle</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q13627-1</id>
<name>Long</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q13627-2</id>
<name>1</name>
<sequence type="described" ref="VSP_004917"/>
</isoform>
<isoform>
<id>Q13627-3</id>
<name>2</name>
<sequence type="described" ref="VSP_004918 VSP_004919"/>
</isoform>
<isoform>
<id>Q13627-4</id>
<name>3</name>
<sequence type="described" ref="VSP_004920 VSP_004921"/>
</isoform>
<isoform>
<id>Q13627-5</id>
<name>4</name>
<sequence type="described" ref="VSP_004922 VSP_004923"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="tissue specificity">
<text evidence="13 29 30 31">Ubiquitous. Highest levels in skeletal muscle, testis, fetal lung and fetal kidney.</text>
</comment>
<comment type="developmental stage">
<text evidence="29">Expressed in the developing central nervous system. Overexpressed 1.5-fold in fetal Down syndrome brain.</text>
</comment>
<comment type="domain">
<text evidence="17">The polyhistidine repeats act as targeting signals to nuclear speckles.</text>
</comment>
<comment type="PTM">
<text evidence="26">Autophosphorylated on numerous tyrosine residues. Can also autophosphorylate on serine and threonine residues (in vitro).</text>
</comment>
<comment type="disease" evidence="21 24">
<disease id="DI-03186">
<name>Mental retardation, autosomal dominant 7</name>
<acronym>MRD7</acronym>
<description>A disease characterized by primary microcephaly, severe mental retardation without speech, anxious autistic behavior, and dysmorphic features, including bitemporal narrowing, deep-set eyes, large simple ears, and a pointed nasal tip. Mental retardation is characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.</description>
<dbReference type="MIM" id="614104"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="35">Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MNB/DYRK subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/DYRK1AID43234ch21q22.html"/>
</comment>
<dbReference type="EC" id="2.7.12.1" evidence="19 23 26 28"/>
<dbReference type="EMBL" id="U58496">
<property type="protein sequence ID" value="AAC50939.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U52373">
<property type="protein sequence ID" value="AAB18639.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D85759">
<property type="protein sequence ID" value="BAA12866.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D86550">
<property type="protein sequence ID" value="BAA13110.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF108830">
<property type="protein sequence ID" value="AAD31169.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ001870">
<property type="protein sequence ID" value="CAA05059.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13653.1">
<molecule id="Q13627-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13654.1">
<molecule id="Q13627-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS42925.1">
<molecule id="Q13627-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS42926.1">
<molecule id="Q13627-5"/>
</dbReference>
<dbReference type="PIR" id="JC4898">
<property type="entry name" value="JC4898"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001334650.1">
<molecule id="Q13627-2"/>
<property type="nucleotide sequence ID" value="NM_001347721.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001334651.1">
<molecule id="Q13627-2"/>
<property type="nucleotide sequence ID" value="NM_001347722.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001387.2">
<molecule id="Q13627-1"/>
<property type="nucleotide sequence ID" value="NM_001396.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_567824.1">
<molecule id="Q13627-5"/>
<property type="nucleotide sequence ID" value="NM_101395.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_569120.1">
<molecule id="Q13627-2"/>
<property type="nucleotide sequence ID" value="NM_130436.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_569122.1">
<molecule id="Q13627-3"/>
<property type="nucleotide sequence ID" value="NM_130438.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006724039.1">
<molecule id="Q13627-1"/>
<property type="nucleotide sequence ID" value="XM_006723976.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006724040.1">
<molecule id="Q13627-1"/>
<property type="nucleotide sequence ID" value="XM_006723977.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006724041.1">
<molecule id="Q13627-1"/>
<property type="nucleotide sequence ID" value="XM_006723978.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011527785.1">
<molecule id="Q13627-1"/>
<property type="nucleotide sequence ID" value="XM_011529483.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016883773.1">
<molecule id="Q13627-2"/>
<property type="nucleotide sequence ID" value="XM_017028284.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.368240"/>
<dbReference type="PDB" id="2VX3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D=127-485"/>
</dbReference>
<dbReference type="PDB" id="2WO6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=127-485"/>
</dbReference>
<dbReference type="PDB" id="3ANQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C/D=126-490"/>
</dbReference>
<dbReference type="PDB" id="3ANR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C/D=126-490"/>
</dbReference>
<dbReference type="PDB" id="4AZE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.15"/>
<property type="chains" value="A/B/C=128-485"/>
</dbReference>
<dbReference type="PDB" id="4MQ1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B/C/D=127-485"/>
</dbReference>
<dbReference type="PDB" id="4MQ2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C/D=127-485"/>
</dbReference>
<dbReference type="PDB" id="4NCT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C/D=126-490"/>
</dbReference>
<dbReference type="PDB" id="4YLJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A/B/C/D=127-485"/>
</dbReference>
<dbReference type="PDB" id="4YLK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=127-485"/>
</dbReference>
<dbReference type="PDB" id="4YLL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=127-485"/>
</dbReference>
<dbReference type="PDB" id="4YU2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D=127-485"/>
</dbReference>
<dbReference type="PDB" id="5A3X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.26"/>
<property type="chains" value="A/B/C/D=126-490"/>
</dbReference>
<dbReference type="PDB" id="5A4E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.68"/>
<property type="chains" value="A/B/C/D=126-490"/>
</dbReference>
<dbReference type="PDB" id="5A4L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A/B/C/D=126-490"/>
</dbReference>
<dbReference type="PDB" id="5A4Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.37"/>
<property type="chains" value="A/B/C/D=126-490"/>
</dbReference>
<dbReference type="PDB" id="5A4T">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B/C/D=126-490"/>
</dbReference>
<dbReference type="PDB" id="5A54">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.63"/>
<property type="chains" value="A/B/C/D=126-490"/>
</dbReference>
<dbReference type="PDB" id="5AIK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B/C/D=128-485"/>
</dbReference>
<dbReference type="PDBsum" id="2VX3"/>
<dbReference type="PDBsum" id="2WO6"/>
<dbReference type="PDBsum" id="3ANQ"/>
<dbReference type="PDBsum" id="3ANR"/>
<dbReference type="PDBsum" id="4AZE"/>
<dbReference type="PDBsum" id="4MQ1"/>
<dbReference type="PDBsum" id="4MQ2"/>
<dbReference type="PDBsum" id="4NCT"/>
<dbReference type="PDBsum" id="4YLJ"/>
<dbReference type="PDBsum" id="4YLK"/>
<dbReference type="PDBsum" id="4YLL"/>
<dbReference type="PDBsum" id="4YU2"/>
<dbReference type="PDBsum" id="5A3X"/>
<dbReference type="PDBsum" id="5A4E"/>
<dbReference type="PDBsum" id="5A4L"/>
<dbReference type="PDBsum" id="5A4Q"/>
<dbReference type="PDBsum" id="5A4T"/>
<dbReference type="PDBsum" id="5A54"/>
<dbReference type="PDBsum" id="5AIK"/>
<dbReference type="ProteinModelPortal" id="Q13627"/>
<dbReference type="SMR" id="Q13627"/>
<dbReference type="BioGrid" id="108192">
<property type="interactions" value="76"/>
</dbReference>
<dbReference type="DIP" id="DIP-39750N"/>
<dbReference type="ELM" id="Q13627"/>
<dbReference type="IntAct" id="Q13627">
<property type="interactions" value="35"/>
</dbReference>
<dbReference type="MINT" id="MINT-1205413"/>
<dbReference type="STRING" id="9606.ENSP00000381932"/>
<dbReference type="BindingDB" id="Q13627"/>
<dbReference type="ChEMBL" id="CHEMBL2292"/>
<dbReference type="DrugBank" id="DB07608">
<property type="generic name" value="N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2009"/>
<dbReference type="iPTMnet" id="Q13627"/>
<dbReference type="PhosphoSitePlus" id="Q13627"/>
<dbReference type="BioMuta" id="DYRK1A"/>
<dbReference type="DMDM" id="3219996"/>
<dbReference type="EPD" id="Q13627"/>
<dbReference type="MaxQB" id="Q13627"/>
<dbReference type="PaxDb" id="Q13627"/>
<dbReference type="PeptideAtlas" id="Q13627"/>
<dbReference type="PRIDE" id="Q13627"/>
<dbReference type="DNASU" id="1859"/>
<dbReference type="Ensembl" id="ENST00000338785">
<molecule id="Q13627-5"/>
<property type="protein sequence ID" value="ENSP00000342690"/>
<property type="gene ID" value="ENSG00000157540"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000339659">
<molecule id="Q13627-2"/>
<property type="protein sequence ID" value="ENSP00000340373"/>
<property type="gene ID" value="ENSG00000157540"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000398956">
<molecule id="Q13627-3"/>
<property type="protein sequence ID" value="ENSP00000381929"/>
<property type="gene ID" value="ENSG00000157540"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000398960">
<molecule id="Q13627-1"/>
<property type="protein sequence ID" value="ENSP00000381932"/>
<property type="gene ID" value="ENSG00000157540"/>
</dbReference>
<dbReference type="GeneID" id="1859"/>
<dbReference type="KEGG" id="hsa:1859"/>
<dbReference type="UCSC" id="uc002ywi.4">
<molecule id="Q13627-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1859"/>
<dbReference type="DisGeNET" id="1859"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000157540.19"/>
<dbReference type="GeneCards" id="DYRK1A"/>
<dbReference type="HGNC" id="HGNC:3091">
<property type="gene designation" value="DYRK1A"/>
</dbReference>
<dbReference type="HPA" id="HPA015323"/>
<dbReference type="HPA" id="HPA015810"/>
<dbReference type="MalaCards" id="DYRK1A"/>
<dbReference type="MIM" id="600855">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="614104">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13627"/>
<dbReference type="OpenTargets" id="ENSG00000157540"/>
<dbReference type="Orphanet" id="178469">
<property type="disease" value="Autosomal dominant non-syndromic intellectual disability"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27545"/>
<dbReference type="eggNOG" id="KOG0667">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XPET">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119032"/>
<dbReference type="HOGENOM" id="HOG000220863"/>
<dbReference type="HOVERGEN" id="HBG051425"/>
<dbReference type="InParanoid" id="Q13627"/>
<dbReference type="KO" id="K08825"/>
<dbReference type="OMA" id="RQGIDRE"/>
<dbReference type="OrthoDB" id="EOG091G03J7"/>
<dbReference type="PhylomeDB" id="Q13627"/>
<dbReference type="TreeFam" id="TF314624"/>
<dbReference type="BRENDA" id="2.7.12.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1538133">
<property type="pathway name" value="G0 and Early G1"/>
</dbReference>
<dbReference type="SignaLink" id="Q13627"/>
<dbReference type="SIGNOR" id="Q13627"/>
<dbReference type="ChiTaRS" id="DYRK1A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q13627"/>
<dbReference type="GeneWiki" id="DYRK1A"/>
<dbReference type="GenomeRNAi" id="1859"/>
<dbReference type="PRO" id="PR:Q13627"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 21"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000157540"/>
<dbReference type="CleanEx" id="HS_DYRK1A"/>
<dbReference type="ExpressionAtlas" id="Q13627">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13627">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030529">
<property type="term" value="C:intracellular ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043621">
<property type="term" value="F:protein self-association"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004712">
<property type="term" value="F:protein serine/threonine/tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048156">
<property type="term" value="F:tau protein binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043518">
<property type="term" value="P:negative regulation of DNA damage response, signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048025">
<property type="term" value="P:negative regulation of mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007399">
<property type="term" value="P:nervous system development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0090312">
<property type="term" value="P:positive regulation of protein deacetylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000381">
<property type="term" value="P:regulation of alternative mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR028318">
<property type="entry name" value="DYRK1A/MNB"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24058:SF28">
<property type="entry name" value="PTHR24058:SF28"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<feature type="chain" description="Dual specificity tyrosine-phosphorylation-regulated kinase 1A" id="PRO_0000085931">
<location>
<begin position="1"/>
<end position="763"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="12">
<location>
<begin position="159"/>
<end position="479"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="35">
<location>
<begin position="165"/>
<end position="173"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="35">
<location>
<begin position="238"/>
<end position="241"/>
</location>
</feature>
<feature type="short sequence motif" description="Bipartite nuclear localization signal" evidence="11">
<location>
<begin position="117"/>
<end position="134"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="509"/>
<end position="515"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-His">
<location>
<begin position="599"/>
<end position="602"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-His">
<location>
<begin position="607"/>
<end position="619"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser/Thr-rich">
<location>
<begin position="656"/>
<end position="672"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="664"/>
<end position="671"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="36">
<location>
<position position="287"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="35">
<location>
<position position="188"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="14"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="111"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="140"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="5 6">
<location>
<position position="145"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="159"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="177"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="9">
<location>
<position position="219"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="26">
<location>
<position position="310"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="319"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="321"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="26">
<location>
<position position="402"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="449"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="529"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="538"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="748"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="758"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 1." id="VSP_004917" evidence="33 34">
<location>
<begin position="70"/>
<end position="78"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_004918" evidence="35">
<original>GGSSGTSNSGRARS</original>
<variation>GASAISCSSWLVRH</variation>
<location>
<begin position="516"/>
<end position="529"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_004920" evidence="35">
<original>GGSSGTSNSG</original>
<variation>GGAALDARCL</variation>
<location>
<begin position="516"/>
<end position="525"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_004921" evidence="35">
<location>
<begin position="526"/>
<end position="763"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_004919" evidence="35">
<location>
<begin position="530"/>
<end position="763"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_004922" evidence="32">
<original>RQQFPAPLGWSGTEAPTQVTVETHPV</original>
<variation>SSHVVHLLVSPAILRWSSTGCQVPLE</variation>
<location>
<begin position="559"/>
<end position="584"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_004923" evidence="32">
<location>
<begin position="585"/>
<end position="763"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_009395" evidence="13">
<original>Y</original>
<variation>F</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55720916." id="VAR_040453" evidence="16 31">
<original>A</original>
<variation>P</variation>
<location>
<position position="679"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_009396" evidence="13">
<original>Q</original>
<variation>H</variation>
<location>
<position position="681"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="26">
<original>K</original>
<variation>R</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mildly reduces kinase activity. Does not abolish autophosphorylation on tyrosine residues." evidence="26">
<original>Y</original>
<variation>F</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50939." ref="1" evidence="35">
<original>G</original>
<variation>A</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50939." ref="1" evidence="35">
<original>N</original>
<variation>S</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50939." ref="1" evidence="35">
<original>S</original>
<variation>P</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50939." ref="1" evidence="35">
<original>Q</original>
<variation>R</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; CAA05059." ref="6" evidence="35">
<original>A</original>
<variation>V</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; CAA05059." ref="6" evidence="35">
<original>G</original>
<variation>R</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50939." ref="1" evidence="35">
<original>K</original>
<variation>N</variation>
<location>
<position position="397"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50939." ref="1" evidence="35">
<original>A</original>
<variation>G</variation>
<location>
<position position="592"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="137"/>
<end position="139"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="156"/>
<end position="158"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="159"/>
<end position="168"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="171"/>
<end position="178"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="179"/>
<end position="182"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="183"/>
<end position="190"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="194"/>
<end position="212"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="214"/>
<end position="217"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="219"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="224"/>
<end position="230"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="233"/>
<end position="239"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="245"/>
<end position="251"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="252"/>
<end position="254"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="259"/>
<end position="276"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="279"/>
<end position="281"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="290"/>
<end position="292"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="293"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="308"/>
<end position="310"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="314"/>
<end position="316"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="325"/>
<end position="327"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="330"/>
<end position="333"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="341"/>
<end position="356"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="366"/>
<end position="377"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="382"/>
<end position="385"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="391"/>
<end position="394"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="395"/>
<end position="397"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="403"/>
<end position="405"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="423"/>
<end position="426"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="427"/>
<end position="432"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="434"/>
<end position="436"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="437"/>
<end position="440"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="446"/>
<end position="459"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="464"/>
<end position="466"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="470"/>
<end position="475"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="477"/>
<end position="479"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2WO6"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4YLK"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4YU2"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61214"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q63470"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9NR20"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255"/>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10329007"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14500717"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14593110"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19266028"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20167603"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20981014"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21127067"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21294719"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22767602"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22998443"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23160955"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23415227"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23665168"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23864635"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24239188"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8769099"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8872470"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8975710"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10329007"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8769099"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9037601"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000305"/>
<evidence key="36" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="23665168"/>
</source>
</evidence>
<sequence length="763" mass="85584" checksum="7C3A52A3CBB04FB5" modified="1998-07-15" version="2">
MHTGGETSACKPSSVRLAPSFSFHAAGLQMAGQMPHSHQYSDRRQPNISDQQVSALSYSD
QIQQPLTNQVMPDIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQ
QGQGDDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV
EQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM
LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR
SAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL
FSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGT
RKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK
KTADEGTNTSNSVSTSPAMEQSQSSGTTSSTSSSSGGSSGTSNSGRARSDPTHQHRHSGG
HFTAAVQAMDCETHSPQVRQQFPAPLGWSGTEAPTQVTVETHPVQETTFHVAPQQNALHH
HHGNSSHHHHHHHHHHHHHGQQALGNRTRPRVYNSPTNSSSTQDSMEVGHSHHSMTSLSS
STTSSSTSSSSTGNQGNQAYQNRPVAANTLDFGQNGAMDVNLTVYSNPRQETGIAGHPTY
QFSANTGPAHYMTEGHLTMRQGADREESPMTGVCVQQSPVASS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>